Written Consent Right

A written consent right is a mechanism that permits shareholders to take action on corporate matters by signing and submitting written consent, bypassing the need to hold a formal shareholders’ meeting. This power shifts decision-making authority from the boardroom calendar to the shareholder base itself, enabling faster approvals when consensus is strong.

Why shareholders need a mechanism to act without meetings

Shareholders collectively own a company, yet formal shareholder meetings are expensive, time-consuming, and logistically complex to convene. A traditional special meeting might require 30–60 days’ notice, venue rental, management presentation, proxy cards, and balloting. For routine decisions or when shareholder interest is near-unanimous, this apparatus is overkill.

Written consent sidesteps that friction. It allows shareholders to signal approval through simple signed documentation—physical signatures, electronic signatures, or even email confirmations, depending on the bylaws. This is especially valuable for closely held companies where shareholders are few and agreement is likely, but also exists in large public firms where activist investors might orchestrate rapid action on a time-sensitive matter.

The mechanism reflects a balance in corporate law: boards run day-to-day operations, but shareholders retain ultimate power over major corporate events. Written consent lets that power activate quickly when shareholders align.

How written consent actually works

The process typically unfolds in stages. First, a shareholder (or group of shareholders) drafts a consent form describing the action to be approved—for instance, “the shareholders hereby approve the merger with Company X on the terms set forth in the merger agreement.” The form is then circulated to all other shareholders entitled to vote.

Depending on the company’s bylaws, shareholders sign and return the form within a specified window. Once a majority (or the stipulated threshold) has consented, the action is approved. No meeting occurs; no proxies are solicited. The company files the consent documentation in its records, and the action becomes effective according to its terms.

In large public companies, this process is rarer and often contested. Activist investors may seek to mount a written consent campaign to oust board members or force a strategic decision. Here, consent becomes a political tool: management may actively argue shareholders should withhold consent, and proxy advisors weigh in on voting recommendation. The speed advantage can favour those who organize first.

State law varies. Delaware, which incorporates roughly half of U.S. public companies, permits written consent unless the certificate of incorporation or bylaws forbid it. Many companies proactively disable written consent in their charter to prevent surprise shareholder action. Other states (like California) presumptively allow it. This creates an asymmetry: a board that fears shareholder activism will lobby to amend the bylaws to eliminate consent rights entirely.

The strategic tension: management versus activist shareholders

Written consent has become a flashpoint in governance design. Boards like it in calm times (it is cheap to use), but fear it in tense situations. An activist investor who has built a stake might use written consent to force a shareholder derivative suit, elect new directors, or demand a strategic sale.

Management typically responds by:

• Amending the charter to prohibit written consent (a move that itself usually requires shareholder vote, but is hard to block at an annual meeting where most shareholders are passive).
• Requiring unanimous consent for certain actions, making mobilization nearly impossible.
• Conditioning consent on a quorum—for example, requiring that holders of 50% of all outstanding shares consent, not just 50% of those who respond.

Supporters of written consent argue it deepens democratic accountability and forces boards to stay attuned to shareholder sentiment. Critics counter that it enables minority activists to hijack governance during momentary share price dips, disrupting long-term strategy. The tension has no permanent resolution; it swings with the climate for activism and shareholder rights.

Written consent in private companies versus public firms

In closely held companies, written consent is standard practice. A three-person partnership rarely wants to stage a formal meeting for every decision. Bylaws typically allow consent, and shareholders exercise it often and casually—a series of consent forms might accumulate over a year, approving new hires, lease renewals, or shareholder loans.

Public companies are different. Most large-cap firms have disabled written consent or imposed such restrictive conditions that it is useless. This reflects both the scale (thousands of shareholders make organizing consent logistically nightmarish) and risk (a determined activist with 10% could, in theory, muster enough consents to force a board election or sale without waiting for the annual meeting).

However, written consent can still flare up in the public markets, especially if a company faces a proxy fight. An activist may threaten a written consent campaign to add urgency to negotiations, or board opponents may invoke consent to unseat a sitting director mid-year.

Intersection with proxy voting and voting rights

Written consent sits alongside proxy voting as a method for shareholders to act. Proxy voting is the standard mechanism: shareholders receive a proxy statement at the annual meeting and vote for directors and proposals. Written consent is the shortcut: no meeting, no waiting.

Some companies have moved to “proxy access,” allowing large long-term shareholders to nominate directors directly in the proxy statement, reducing the need for a written consent challenge. This is a partial concession to shareholder power—it lets governance move faster than a traditional slate, but still within the annual meeting cycle.

The interplay matters. If written consent is forbidden, the annual meeting becomes the only lever shareholders have, making that one vote per year critical. If written consent is allowed, a board cannot take shareholder will for granted between annual meetings; an activist campaign can materialize in weeks.

See also